Biomarker substudy of #SLE Rx w/ low dose IL-2 Rx in 342 pts (40% responders). SRI-4 predicted by rash, proteinuria, uRBC, %CD4 T cells, C3 (AUC 0.9330; however renal markers did not correlate with achieving LLDAS. https://t.co/pDgwegbU6t https://t.co/72w4gNAiWt
Links:
Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus eryt…
https://buff.ly/3NXnEvH
Oct-23-2024
